Approval · Notice of Compliance 6730 · 2005
ZEVALIN: Notice of Compliance 6730
Issued May 10, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6730
- Date
- May 10, 2005
- Company
- Berlex Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Therapeutic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVALIN | Not yet assigned | — |
Medicinal ingredients
- IBRITUMOMAB TIUXETAN 3.2 MG per 2ML